Buprenorphine treatment for hospitalized, opioid-dependent patients: A randomized clinical trial

JAMA Internal Medicine

Volumn 174, Issue 8, 2014, Pages 1369-1376

  Liebschutz, Jane M ^a,b   Crooks, Denise ^a   Herman, Debra ^c,d   Anderson, Bradley ^c,d   Tsui, Judith ^a,b   Meshesha, Lidia Z ^e   Dossabhoy, Shernaz ^a   Stein, Michael ^c,d  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BUTLER HOSPITAL   (United States)

^d BROWN UNIVERSITY   (United States)

^e University of Memphis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; NARCOTIC AGENT;

ADULT; AMBULATORY CARE; CONTROLLED STUDY; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UTILIZATION;

ADULT; AMBULATORY CARE; BUPRENORPHINE; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT DISCHARGE; TREATMENT OUTCOME;

EID: 84905816424     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.2556     Document Type: Article

References (31)

1. Brown RL, Leonard T, Saunders LA, Papasouliotis O. The prevalence and detection of substance use disorders among inpatients ages 18 to 49: an opportunity for prevention. Prev Med. 1998;27(1): 101-110. doi: 10.1006/pmed.1997.0250.
2. Cherpitel CJ, Ye Y. Drug use and problem drinking associated with primary care and emergency room utilization in the US general population: data from the 2005 National Alcohol Survey. Drug Alcohol Depend. 2008;97(3): 226-230.
3. Moore RD, Bone LR, Geller G, Mamon JA, Stokes EJ, Levine DM. Prevalence, detection, and treatment of alcoholism in hospitalized patients. JAMA. 1989;261(3): 403-407.
4. Stein MD,Wilkinson J, Berglas N, O'Sullivan P. Prevalence and detection of illicit drug disorders among hospitalized patients. Am J Drug Alcohol Abuse. 1996;22(3): 463-471.
5. Katz A, Goldberg D, Smith J, TrickWE. Tobacco, alcohol, and drug use among hospital patients: concurrent use and willingness to change. J Hosp Med. 2008;3(5): 369-375.
6. McNeely J, Gourevitch MN, Paone D, Shah S, Wright S, Heller D. Estimating the prevalence of illicit opioid use in New York City using multiple data sources. BMC Public Health. 2012;12: 443. doi: 10.1186/1471-2458-12-443.
7. Rigotti NA, MunafoMR, Stead LF. Smoking cessation interventions for hospitalized smokers: a systematic review. Arch InternMed. 2008;168 (18): 1950-1960.
8. Saitz R, Palfai TP, Cheng DM, et al. Brief intervention for medical inpatients with unhealthy alcohol use: a randomized, controlled trial. Ann Intern Med. 2007;146(3): 167-176.
9. Chick J, Lloyd G, Crombie E. Counselling problem drinkers in medical wards: a controlled study. Br Med J (Clin Res Ed). 1985;290(6473): 965-967.
10. Freyer-Adam J, Coder B, Baumeister SE, et al. Brief alcohol intervention for general hospital inpatients: a randomized controlled trial. Drug Alcohol Depend. 2008;93(3): 233-243.
11. Watson HE. A study of minimal interventions for problem drinkers in acute care settings. Int J Nurs Stud. 1999;36(5): 425-434.
12. Substance Abuse and Mental Health Services Administration. Drug abuse warning network, 2011: national estimates of drug-related emergency department visits. http://www.samhsa.gov/data/2k13/DAWN2k11ED/DAWN2k11ED.htm#5.1. Accessed September 17, 2013.
13. Stein MD. Medical consequences of substance abuse. Psychiatr Clin North Am. 1999;22(2): 351-370.
14. Umbricht A, Hoover DR, Tucker MJ, Leslie JM, Chaisson RE, Preston KL. Opioid detoxification with buprenorphine, clonidine, ormethadone in hospitalized heroin-dependent patients with HIV infection. Drug Alcohol Depend. 2003;69(3): 263-272.
15. Kosten TR, O'Connor PG. Management of drug and alcohol withdrawal. N Engl J Med. 2003;348 (18): 1786-1795.
16. Smothers BA, Yahr HT, Ruhl CE. Detection of alcohol use disorders in general hospital admissions in the United States. Arch Intern Med. 2004;164 (7): 749-756.
17. Zanis DA,Woody GE. One-year mortality rates following methadone treatment discharge. Drug Alcohol Depend. 1998;52(3): 257-260.
18. Yancovitz SR, Des Jarlais DC, Peyser NP, et al. A randomized trial of an interim methadone maintenance clinic. Am J Public Health. 1991;81(9): 1185-1191.
19. Stancliff S, Joseph H, Fong C, Furst T, Comer SD, Roux P. Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations. J Addict Dis. 2012;31(3): 278-287.
20. Johnson RE, Eissenberg T, Stitzer ML, Strain EC, Liebson IA, Bigelow GE. A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug Alcohol Depend. 1995;40 (1): 17-25.
21. Kakko J, Grönbladh L, Svanborg KD, et al. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. Am J Psychiatry. 2007;164(5): 797-803.
22. Shanahan CW, Beers D, Alford DP, Brigandi E, Samet JH. A transitional opioid program to engage hospitalized drug users. J Gen Intern Med. 2010; 25(8): 803-808.
23. Sobell LC, Sobell MB, Maisto SA, Cooper AM. Time-line follow-back assessment method. In: Lettieri DJ, SayersMA, Nelson JE, eds. NIAAA Treatment Handbook Series: Alcoholism Treatment Assessment Research Instruments. Washington, DC: National Institute on Alcoholism and Alcohol Abuse; 1979: 530-534.
24. McLellan AT, Alterman AI, Cacciola J,Metzger D, O'Brien CP. A new measure of substance abuse treatment: initial studies of the treatment services review. J Nerv Ment Dis. 1992;180(2): 101-110.
25. Efron B, Tibshirani R. An Introduction to the Bootstrap. New York, NY: Chapman & Hall; 1993.
26. Alford DP, LaBelle CT, Kretsch N, et al. Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience. Arch Intern Med. 2011;171(5): 425-431.
27. Stein MD, Anderson B. Injection frequency mediates health service use among persons with a history of drug injection. Drug Alcohol Depend. 2003;70(2): 159-168.
28. Neumann AM, Blondell RD, AzadfardM, Nathan G, Homish GG. Primary care patient characteristics associated with completion of 6-month buprenorphine treatment. Addict Behav. 2013;38(11): 2724-2728.
29. Stein MD, Cioe P, Friedmann PD. Buprenorphine retention in primary care. J Gen Intern Med. 2005;20(11): 1038-1041. doi: 10.1111/j.1525-1497.2005.0228.x.
30. Haddad MS, Zelenev A, Altice FL. Integrating buprenorphine maintenance therapy into federally qualified health centers: real-world substance abuse treatment outcomes. Drug Alcohol Depend. 2013;131(1-2): 127-135.
31. Koester KA, Morewitz M, Pearson C, et al. Patient navigation facilitates medical and social services engagement among HIV-infected individuals leaving jail and returning to the community. AIDS Patient Care STDS. 2014;28(2): 82-90.